CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer
CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab [Yahoo! Finance]
CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab
Creatv Bio's LifeTracDx® Blood Test Utilized as Exploratory Biomarker in CytoDyn's Phase 2 Study in Patients with Relapsed/Refractory Metastatic Colorectal Cancer [Yahoo! Finance]
CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference